Lizzo broke her silence on weight loss rumors and shared new details about her health journey. Here's everything you need to ...

Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on ...

Danish company Novo Nordisk is poised to bring to India its injectable semaglutide — globally popular as Wegoy/Ozempic for ...

The decision to advance the trials is based on feedback received from regulatory authorities in interactions following the ...

He spotted the opportunity to invest in weight-loss drugs in 2023 before they exploded in 2024, and was an early AI mover, which he spied as a game changer in late 2022, early 2023. It’s all ...

Appetite-suppressing drugs could wipe out millions of fast-food trips. What it means for your choices and your money.

ZURICH (Reuters) -UBS finance chief Todd Tuckner voiced his disappointment on Wednesday over proposed new Swiss capital ...

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

suburbs to South Jersey and Delaware, what would you like WHYY News to cover? Let us know! Ever since blockbuster weight-loss drugs like Wegovy and Zepbound went mainstream, calls to local poison ...

A UK watchdog is urging women on GLP-1 weight-loss drugs like Ozempic and Mounjaro to use effective forms of birth control after receiving more than 40 pregnancy-related reports linked to the ...

Novo Nordisk A/S's NVO semaglutide, a GLP-1 receptor agonist, is the active substance in certain medicines used for diabetes and obesity (Ozempic, Rybelsus, and Wegovy). After reviewing all ...

June 6 (Reuters) - Novo Nordisk's (NOVOb.CO), opens new tab popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition that can lead to vision ...